Capecitabine in Combination With Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer, a Phase II Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Bendamustine (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms MBC-6
- 22 Dec 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2017.
- 22 Dec 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Dec 2017.
- 11 Oct 2016 Results assessing safety parameters presented at the 41st European Society for Medical Oncology Congress (2016).